Paladin Labs Signs Agreement With QRxPharma for Acute Pain Product

Paladin Labs entered into a licensing agreement with QRxPharma Limited, an Australian-based specialty pharmaceutical company, whereby Paladin received the exclusive rights to market and sell Moxduo (morphine and oxycodone) in Canada.
Equities